- Reaction score
- 188
Hopefully monoclonal antibody production becomes cheaper over the next few years. The prices on average are very expensive but there's also a ton of variance within that range. Logically I don't think they would clear 8 figures of financing if they didnt expect to offer this at Mass market (ish) prices.
